Litvin Centers For Diabetes West Orange, NJ - 07052

Litvin Centers For Diabetes is categorized under Physicians and Surgeons Information Bureaus in West Orange, NJ .

Litvin Centers For Diabetes was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians and Surgeons Information Bureaus business, which does work in the B2C market, and is classified as a Physicians and Surgeons Information Bureaus, under code number 6219994 by the NAICS.

If you are seeking more information, feel free to contact at the company’s single location by writing to 622 Eagle Rock Avenue, West Orange, New Jersey NJ 07052 or by phoning (973) 736-1221. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Litvin Centers For Diabetes
Address: 622 Eagle Rock Avenue, West Orange, New Jersey 07052
Phone Number: (973) 736-1221
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physicians and Surgeons Information Bureaus
SIC Code: 8099
NAICS Code: 6219994
Share This Business:

Litvin Centers For Diabetes was started in 0 to provide professional Physicians and Surgeons Information Bureaus under the SIC code 8099 and NAICS code 6219994. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact for inquiries that concern Litvin Centers For Diabetes by calling the company number (973) 736-1221, as your correspondence is most welcome. Additionally, the physical location of the single location of Litvin Centers For Diabetes can be found at the coordinates 40.80979,-74.25805 as well as the street address 622 Eagle Rock Avenue in West Orange, New Jersey 07052.

For its online presence, you may visit Litvin Centers For Diabetes’s website at and engage with its social media outlets through on Twitter and on Facebook.